The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Table 22.22

Cancer of the Pancreas (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2012-2016
Both Sexes by Race

Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 69,818 98.4% 55,902 98.5% 8,656 98.4% 4,643 98.3% 232 96.7% 7,299 98.2%
Epidermoid carcinomad (8051-8131) 192 0.3% 146 0.3% 26 0.3% 17 0.4% - - 21 0.3%
Adenocarcinomae 60,326 85.0% 48,497 85.4% 7,434 84.5% 3,910 82.8% 193 80.4% 6,278 84.4%
Adenocarcinoma, NOS (8140) 47,997 67.7% 38,596 68.0% 6,045 68.7% 2,981 63.1% 153 63.8% 4,890 65.8%
Papillary adenocarcinoma, NOS (8260) 44 0.1% 33 0.1% - - - - - - - -
Mucinous adenocarcinoma (8480,8482) 1,567 2.2% 1,272 2.2% 149 1.7% 128 2.7% - - 189 2.5%
Mucin-producing adenocarcinoma (8481) 384 0.5% 305 0.5% 54 0.6% 24 0.5% - - 39 0.5%
Infiltrating duct carcinoma (8500-8503,8507,8514) 8,238 11.6% 6,606 11.6% 947 10.8% 618 13.1% 24 10.0% 871 11.7%
Other adenocarcinomaf 2,096 3.0% 1,685 3.0% 234 2.7% 153 3.2% - - 278 3.7%
Other specific carcinomasg 6,956 9.8% 5,483 9.7% 844 9.6% 524 11.1% 24 10.0% 738 9.9%
Islet cell carcinoma (8150-8155) 362 0.5% 301 0.5% 41 0.5% 16 0.3% - - 30 0.4%
Other carcinomash 6,594 9.3% 5,182 9.1% 803 9.1% 508 10.8% 22 9.2% 708 9.5%
Unspecified, "Carcinoma, NOS" (8010,8020-8022) 2,344 3.3% 1,776 3.1% 352 4.0% 192 4.1% - - 262 3.5%
Sarcoma and other soft tissue tumorsi 55 0.1% 45 0.1% - - - - - - - -
Other specific typesj Unspecified (8000-8005) 78 0.1% 61 0.1% - - - - - - - -
979 1.4% 769 1.4% 128 1.5% 70 1.5% - - 113 1.5%
Total 70,932 100.0% 56,779 100.0% 8,796 100.0% 4,725 100.0% 240 100.0% 7,436 100.0%

Footnotes:

Source: SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the Purchased/Referred Care Delivery Area (PRCDA) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8050,8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941.

f Other adenocarcinoma include histologies 8050,8141-8147,8160-8162,8180-8221,8250-8259,8261-8479,8483-8499,8504-8506,8520-8551, 8560,8570-8574,8576,8940-8941.

g Other specific carcinomas include histologies 8012-8015,8030-8046,8150-8155,8170-8180,8230-8249,8508,8510-8513,8561-8562,8575, 8580-8671.

h Other carcinomas include histologies 8012-8015,8030-8046,8170-8180,8230-8249,8508,8510-8513,8561-8562,8575,8580-8671.

i Sarcoma and other soft tissue tumors include histologies 8680-8713,8800-8921,8990-8991,9040-9044,9120-9136,9150-9252,9370-9373, 9540-9582.

j Other specific types include histologies 8720-8790,8930-8936,8950-9030,9060-9110,9260-9365,9380-9539.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.